1061 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Essex Bio-Technology Ltd. is an investment holding company, which engages in the development, manufacture, and sale of biopharmaceutical products. It operates through the Ophthalmology and Surgical segments. The company was founded by Mia Je Ngiam in February 1999 and is headquartered in Hong Kong.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
1061 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company